Fig. 3From: Pharmacokinetics and brain distribution of the therapeutic peptide liraglutide by a novel LC–MS/MS analysisPlasma concentration–time profiles of liraglutide following intravenous (IV, 0.05 mg/kg) and subcutaneous (SC, 1 mg/kg) injection in rats A on a linear plot and B on a semi-log plot (mean ± SD, n = 5)Back to article page